Skip to main content

Table 1 Demographic characteristics

From: Association between cardiovascular disease- and inflammation-related serum biomarkers and poor lung function in elderly

 

FEV1/FVC  ≥  LLN

FEV1/FVC  <  LLN

Missing FEV1/FVC

Sex

 Male (n, %)

256 (46.7)

21 (33.3)

18 (41.9)

 Female (n, %)

292 (53.3)

42 (66.7)

25 (58.1)

Age

 N

548

63

43

 Median

77

78

72

 Min.

66

66

60

 Max.

86

85

85

BMI

 N

547

62

39

 Median

26.7

25.0

26.3

 Min.

17.9

16.7

18.6

 Max.

44.1

36.9

38.7

Walking test 15 m (sec)

 N

539

60

38

 Median

9.4

10.7

10.5

 Min.

6.2

6.6

7.3

 Max.

19.0

21.9

23.2

Smoking status

 Smoker (n, %)

51 (9.3)

18 (28.6)

3 (7.0)

 Former smoker (n, %)

258 (47.1)

33 (52.4)

25 (58.1)

 Never smoker (n, %)

237 (43.2)

12 (19.0)

15 (34.9)

 Missing (n, %)

2 (0.4)

0 (0.0)

0 (0.0)

Cardiovascular disease

 Angina pectoris

  No (n, %)

502 (91.6)

57 (90.5)

38 (88.4)

  Yes (n, %)

46 (8.4)

6 (9.5)

5 (11.6)

 Ischaemic stroke

  No (n, %)

490 (89.4)

55 (87.3)

36 (83.7)

  Yes (n, %)

58 (10.6)

8 (12.7)

7 (16.3)

 TIA

  No (n, %)

519 (94.7)

60 (95.2)

41 (95.3)

  Yes (n, %)

29 (5.3)

2 (3.2)

2 (4.7)

  Missing (n, %)

0 (0.0)

1 (1.6)

0 (0.0)

 Cerebral hemorrhage

  No (n, %)

546 (99.6)

62 (98.4)

43 (100.0)

  Yes (n, %)

2 (0.4)

1 (1.6)

0 (0.0)

Hypertension

 No (n, %)

272 (49.6)

26 (41.3)

22 (51.2)

 Yes (n, %)

276 (50.4)

37 (58.7)

21 (48.8)

COPD

 No (n, %)

514 (93.8)

25 (39.7)

39 (90.7)

 Yes (n, %)

34 (6.2)

38 (60.3)

4 (9.3)

Diabetes (type I and type II)

 No (n, %)

474 (86.5)

55 (87.3)

38 (88.4)

 Yes (n, %)

74 (13.5)

8 (12.7)

5 (11.6)

FEV1

 N

548

63

43

 Median

2.2

1.4

NA

 Min.

0.8

0.5

NA

 Max.

4.5

2.7

NA

FVC

 N

548

63

43

 Median

2.9

2.6

NA

 Min.

0.8

1.1

NA

 Max.

5.8

4.8

NA

FEV1/FVC

 N

548

63

43

 Median

0.8

0.5

NA

 Min.

0.6

0.3

NA

 Max.

1.0

0.7

NA

  1. TIA transient ischemic attack; COPD chronic obstructive pulmonary disease; BMI body mass index; FEV forced expiratory volume; FVC forced vital capacity